Hongbo Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Patient Reported Outcomes

Ejection Fraction

Top Venues

European journal of neurology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Céline Labeyrie, Madeline Merkel, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Marianne T Sweetser, Hollis Lin, David Adams
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy. European journal of neurology 31 (9) (2024)
Céline Labeyrie, Madeline Merkel, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Marianne T Sweetser, Hollis Lin, David Adams
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy. European journal of neurology 31 (9) (2024)
Céline Labeyrie, Madeline Merkel, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Marianne T Sweetser, Hollis Lin, David Adams
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy. European journal of neurology 31 (9) (2024)
Céline Labeyrie, Madeline Merkel, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Marianne T Sweetser, Hollis Lin, David Adams
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy. European journal of neurology (2024)
Michael R Verneris, Qiufei Ma, Jie Zhang, Amy Keating, Ranjan Tiwari, Junlong Li, Hongbo Yang, Abhijit Agarwal, Lida Pacaud
Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia. Blood advances 5 (23) (2022)
Richard T Maziarz, Jie Zhang, Hongbo Yang, Xinglei Chai, Chengbo Yuan, Elisabeth Schwarz, Mihael Jakovac, Marcela Martinez-Prieto, Abhijit Agarwal, Evgeny Degtyarev, Constantine S Tam, Gilles Andre Salles
Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma. Blood advances 6 (8) (2022)
Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang, Jessie Wang, Kaitlin Hagan, Byron Padilla, Andreas Pinter
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials. Dermatology and therapy 12 (2) (2021)